Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00017433
Status:
TERMINATED
Last Update Posted:
2020-10-06
First Post:
2001-06-06
Brief Title:
Arsenic Trioxide in Treating Patients With Multiple Myeloma
Sponsor:
CTI BioPharma
Organization:
CTI BioPharma
Study Overview
Official Title:
Phase II Study of Arsenic Trioxide in Patients With Multiple Myeloma
Status:
TERMINATED
Status Verified Date:
2020-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
RATIONALE Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die
PURPOSE Phase II trial to study the effectiveness of arsenic trioxide in treating patients who have relapsed or refractory stage II or stage III multiple myeloma
PURPOSE Phase II trial to study the effectiveness of arsenic trioxide in treating patients who have relapsed or refractory stage II or stage III multiple myeloma
Detailed Description:
OBJECTIVES I Determine the response rate of patients with relapsed or refractory stage II or III multiple myeloma treated with arsenic trioxide II Determine the overall and relapse-free survival rates of patients treated with this drug III Determine the safety profile of this drug in these patients
OUTLINE Patients receive arsenic trioxide IV on days 1-5 and 8-12 Treatment repeats every 4 weeks for up to 6 courses Patients are followed at 4 weeks after the last treatment dose
PROJECTED ACCRUAL A total of 55 patients will be accrued for this study
OUTLINE Patients receive arsenic trioxide IV on days 1-5 and 8-12 Treatment repeats every 4 weeks for up to 6 courses Patients are followed at 4 weeks after the last treatment dose
PROJECTED ACCRUAL A total of 55 patients will be accrued for this study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| CDR0000068688 | REGISTRY | PDQ Physician Data Query | None |